Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT

Daniëlle Koopman, J. A. van Dalen, S. Knollema, Cornelis Slump and Pieter Jager
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1380;
Daniëlle Koopman
1Nuclear Medicine, Isala, Zwolle, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. A. van Dalen
2Medical physics, Isala, Zwolle, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Knollema
1Nuclear Medicine, Isala, Zwolle, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis Slump
3MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter Jager
1Nuclear Medicine, Isala, Zwolle, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1380

Objectives To determine the performance of a state-of-the-art Positron Emission Tomography/Computed Tomography (PET/CT) system in the detection and staging of adrenal glands in patients with suspected lung cancer.

Methods We included 79 consecutive patients with suspected lung cancer, who underwent fluorodeoxyglucose (FDG) PET/CT using a novel time-of-flight system (Ingenuity TF, Philips Healthcare). One experienced observer assessed the adrenal gland visibility by viewing PET/CT. Adrenal glands that were not visualized were regarded as ‘undetectable’. Literature reports a detection percentage of 68% [1]. For 30 adrenal glands, we obtained cytological/histological information and calculated the maximum standardized-uptake-value (SUVmax) and the ratio between adrenal gland and liver FDG-uptake (AL-ratio). The optimal cut-off values to distinguish benign from malignant glands were considered to be the values with the highest accuracy. Findings were compared with literature where cut-off values of 2.5 for SUVmax and 1.0 for AL-ratio [2-4] are generally considered typical.

Results Adrenal uptake was frequently seen on PET-only images. In combination with CT, the adrenal glands were detected in 99% of the cases. SUVmax values for benign (n=14) and malignant (n=16) glands were 2.8±0.5 (mean±SD) and 7.4±2.6, respectively (p<0.01). The corresponding AL-ratios were 1.3±0.3 and 3.3±1.3, respectively (p<0.01). Optimal cut-off values for SUVmax and AL-ratio were 4.0 (with accuracy 97%) and 1.9 (accuracy 83%), respectively.

Conclusions The detection performance of adrenal glands using state-of-the-art PET/CT is excellent (99% detected). For accurate distinction between malignant and benign adrenal glands, higher cut-off values for SUVmax and AL-ratio should be used than reported in the literature. Readers and referring physicians should update their cut-off levels when implementing new PET technology.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
Daniëlle Koopman, J. A. van Dalen, S. Knollema, Cornelis Slump, Pieter Jager
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1380;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
Daniëlle Koopman, J. A. van Dalen, S. Knollema, Cornelis Slump, Pieter Jager
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1380;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Preliminary analysis of dynamic [68Ga]PSMAHBED-CC PET/MRI in primary prostate cancer
  • Time of Flight compared to standard iterative acquisition and reconstruction for assessment of pulmonary nodules.
  • Differential metabolic response to chemotherapy between non-Hodgkin's lymphoma and Hodgkin's lymphoma
Show more Oncology: Clinical Diagnosis

MTA I: Lung Cancer Posters

  • Repeatability of quantitative uptake measures of whole body [18F]FDG PET/CT in NSCLC patients.
  • Usefulness of new hypoxia PET tests to estimate the prognosis of non-small cell lung cancer
Show more MTA I: Lung Cancer Posters

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire